Table 3.
Clinical Summary.
| Patient # | FIGO staging 2018 | Neo-adjuvant treatment | Management | Surgical indication | Adjuvant treatment | Remission | PFS (months) | FU (months) | Current status |
|---|---|---|---|---|---|---|---|---|---|
| 1 | IB1 | – | Radical hysterectomy | Standard | – | ✓ | – | 19 | Alive |
| 2 | IB1 | – | Radical hysterectomy | Standard | – | ✓ | – | 54 | Alive |
| 3 | IB2 | CCRT + BT NA intent |
Simple hysterectomy | Poor response to NAT | – | ✓ | – | 8 | Alive |
| 4 | IB3 | CCRT + BT NA intent |
Radical hysterectomy | Poor response to NAT | – | ✓ | – | 76 | Alive |
| 5 | IIB | CCRT Curative intent |
Anterior pelvic exenteration | Poor response to NAT | – | – | 7 | 9 | Deceased |
| 6 | IIB | CCRT + BT Curative intent |
Simple hysterectomy | Poor response to NAT | – | ✓ | – | 123 | Alive |
| 7 | IIIC1 | – | Radical hysterectomy | Clinical stage IB1. Metastatic parametrial nodes on final pathology. | CCRT | ✓ | 36 | 40 | Deceased |
| 8 | IIIC1 | – | Radical hysterectomy | Clinical stage IB2. Metastatic parametrial nodes on final pathology. | CCRT | ✓ | 31 | 59 | Deceased |
| 9 | IIIC1 | CCRT Curative intent |
– | Progression under CRT. Deceased before surgery | – | – | 10 | 13 | Deceased |
| 10 | IVA | – | CCRT curative intent | – | – | 7 | 42 | Deceased | |
| 11 | IVA | – | CCRT curative intent | – | – | 9 | 15 | Deceased | |
| 12 | IVA | – | Palliative RT | – | – | 4 | 11 | Deceased | |
| 13 | IVB | – | Palliative RT + CT | – | – | 2 | 2 | Deceased | |
| 14 | IVB | – | Palliative RT + CT | – | – | 1 | 12 | Deceased |
Abbreviations: NA, Neo-adjuvant; NAT, Neo-adjuvant treatment; CCRT, Concurrent chemoradiotherapy; RT, Radiotherapy; BT, Brachytherapy; DFS, Disease-free survival; PFS, Progression-free survival; FU, Follow-up.